Suppr超能文献

插入设计的螺旋连接子导致基于转录因子的融合蛋白表达增加。

Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.

作者信息

Amet Nurmamet, Lee Hsin-Fang, Shen Wei-Chiang

机构信息

Department of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, PSC 404B, 1985 Zonal Avenue, Los Angeles, California, 90089-9121, USA.

出版信息

Pharm Res. 2009 Mar;26(3):523-8. doi: 10.1007/s11095-008-9767-0. Epub 2008 Nov 11.

Abstract

PURPOSE

To demonstrate a high-level expression of transferrin (Tf)-based fusion proteins by inserting a helical linker between two protein domains.

METHODS

Tf-based fusion proteins were designed to contain oligonucleotides encoding a helical linker inserted between the protein domains. Plasmid constructs were transfected into HEK293 cells and the secreted fusion proteins were purified from conditioned serum free media. Expression was assessed using both SDS-PAGE and Western Blot using anti-hGH, G-CSF, or Tf antibodies; protein bands were analyzed using Quantity One software. The function of fusion proteins consisting of human growth hormone (hGH) and Tf was evaluated in Nb2 cell proliferation assays.

RESULTS

The fusion proteins containing a helical linker, hGH-(H4)(2)-Tf and Tf-(H4)(2)-hGH, were expressed 1.7-and 2.4-fold higher, respectively, with a twofold lower ED(50) than the hGH-Tf fusion protein without a helical linker. The Tf-(H4)(2)-G-CSF fusion protein exhibited a greater expression with an 11.2-fold increase compared with Tf-G-CSF fusion protein.

CONCLUSIONS

The helical linker introduced in Tf-fusion proteins resulted in a high-level of expression with improved in vitro bioactivity. This approach provides a simple method to increase poor expression of other fusion proteins.

摘要

目的

通过在两个蛋白质结构域之间插入螺旋连接子来证明基于转铁蛋白(Tf)的融合蛋白的高水平表达。

方法

设计基于Tf的融合蛋白,使其包含编码插入蛋白质结构域之间的螺旋连接子的寡核苷酸。将质粒构建体转染到HEK293细胞中,并从无血清条件培养基中纯化分泌的融合蛋白。使用抗hGH、G-CSF或Tf抗体通过SDS-PAGE和Western Blot评估表达;使用Quantity One软件分析蛋白条带。在Nb2细胞增殖试验中评估由人生长激素(hGH)和Tf组成的融合蛋白的功能。

结果

含有螺旋连接子的融合蛋白hGH-(H4)(2)-Tf和Tf-(H4)(2)-hGH的表达分别比不含螺旋连接子的hGH-Tf融合蛋白高1.7倍和2.4倍,且ED50低两倍。与Tf-G-CSF融合蛋白相比,Tf-(H4)(2)-G-CSF融合蛋白的表达增加了11.2倍,表现出更高的表达水平。

结论

在Tf融合蛋白中引入的螺旋连接子导致高水平表达并改善了体外生物活性。这种方法提供了一种简单的方法来提高其他融合蛋白的低表达水平。

相似文献

1
Insertion of the designed helical linker led to increased expression of tf-based fusion proteins.
Pharm Res. 2009 Mar;26(3):523-8. doi: 10.1007/s11095-008-9767-0. Epub 2008 Nov 11.
2
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.
J Control Release. 2010 Jan 25;141(2):177-82. doi: 10.1016/j.jconrel.2009.09.007. Epub 2009 Sep 15.
4
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7292-6. doi: 10.1073/pnas.0500062102. Epub 2005 May 3.
6
Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.
Biotechniques. 2010 Jul;49(1):513-8. doi: 10.2144/000113450.
7
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.
Mol Pharm. 2011 Apr 4;8(2):457-65. doi: 10.1021/mp1003064. Epub 2011 Feb 22.
9
Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins.
Pharm Res. 2005 Oct;22(10):1735-46. doi: 10.1007/s11095-005-6489-4. Epub 2005 Sep 22.
10
Circular permutation of granulocyte colony-stimulating factor.
Biochemistry. 1999 Apr 6;38(14):4553-63. doi: 10.1021/bi982224o.

引用本文的文献

2
Screening of Bovine Coronavirus Multiepitope Vaccine Candidates: An Immunoinformatics Approach.
Transbound Emerg Dis. 2024 Jul 18;2024:5986893. doi: 10.1155/2024/5986893. eCollection 2024.
3
Fusing fluorescent proteins and ferritin for protein cage based lighting devices.
Nanoscale. 2025 May 2;17(17):10793-10800. doi: 10.1039/d4nr05261g.
4
Computational Development of Transmission-Blocking Vaccine Candidates Based on Fused Antigens of Pre- and Post-fertilization Gametocytes Against .
Bioinform Biol Insights. 2025 Mar 3;19:11779322241306215. doi: 10.1177/11779322241306215. eCollection 2025.
5
Nanobody-Oligonucleotide Conjugates (NucleoBodies): The Next Frontier in Oligonucleotide Therapy.
Pharm Res. 2025 Feb;42(2):219-236. doi: 10.1007/s11095-025-03829-z. Epub 2025 Feb 15.
6
Development of a Recombinant Fusion Vaccine Candidate Against Lethal Neurotoxin Types A and B.
Vaccines (Basel). 2025 Jan 6;13(1):39. doi: 10.3390/vaccines13010039.
9
Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line.
Res Pharm Sci. 2024 Aug 19;19(4):387-396. doi: 10.4103/RPS.RPS_92_23. eCollection 2024 Aug.
10
In vivo thrombin activity in the diatom Phaeodactylum tricornutum: biotechnological insights.
Appl Microbiol Biotechnol. 2024 Oct 8;108(1):481. doi: 10.1007/s00253-024-13322-z.

本文引用的文献

1
Protein therapeutics: a summary and pharmacological classification.
Nat Rev Drug Discov. 2008 Jan;7(1):21-39. doi: 10.1038/nrd2399.
2
Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.
Nat Biotechnol. 2007 Dec;25(12):1411-9. doi: 10.1038/nbt1364.
3
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin.
Nat Biotechnol. 2007 Nov;25(11):1290-7. doi: 10.1038/nbt1345. Epub 2007 Oct 14.
4
Sodium butyrate alters erythropoietin glycosylation via multiple mechanisms.
Biotechnol Bioeng. 2008 Jan 1;99(1):201-13. doi: 10.1002/bit.21539.
6
Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives.
Biotechnol Lett. 2007 May;29(5):677-84. doi: 10.1007/s10529-006-9297-y. Epub 2007 Jan 19.
8
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7292-6. doi: 10.1073/pnas.0500062102. Epub 2005 May 3.
10
Production of recombinant protein therapeutics in cultivated mammalian cells.
Nat Biotechnol. 2004 Nov;22(11):1393-8. doi: 10.1038/nbt1026.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验